Q4 2023 Holdings
Filed 2024-02-14 | 8 holdings | $509.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ambrx Biopharma Inc | COM | 641871108 | $237.6M | 16,688,636 | 46.6% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $69.1M | 4,046,598 | 13.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $62.8M | 1,039,289 | 12.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $50.1M | 600,000 | 9.8% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $42.2M | 1,060,427 | 8.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $36.4M | 579,959 | 7.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $7.0M | 192,734 | 1.4% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $4.2M | 57,698 | 0.8% |